Michael R Rudnick

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi Contrast-induced nephropathy: how it develops, how to prevent it
    Michael R Rudnick
    University of Pennsylvania School of Medicine, Philadelphia, USA
    Cleve Clin J Med 73:75-80, 83-7. 2006
  2. ncbi Contrast-induced nephropathy: is the picture any clearer?
    Michael R Rudnick
    Section of Nephrology and Hypertension, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Clin J Am Soc Nephrol 3:261-2. 2008
  3. ncbi Contrast-induced nephropathy: what are the true clinical consequences?
    Michael Rudnick
    Renal Electrolyte and Hypertension Division, Penn Presbyterian Medical Center, Philadelphia, Pennsylvania 19104, USA
    Clin J Am Soc Nephrol 3:263-72. 2008
  4. ncbi Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial
    Michael R Rudnick
    Division of Nephrology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Am Heart J 156:776-82. 2008
  5. ncbi Hemodialysis-related venous stenosis: treatment with ultrahigh-pressure angioplasty balloons
    Scott O Trerotola
    Department of Radiology, University of Pennsylvania Medical Center, 1 Silverstein, 3400 Spruce St, Philadelphia, PA 19104, USA
    Radiology 231:259-62. 2004
  6. ncbi Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality
    Michael R Rudnick
    Division of Nephrology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Rev Cardiovasc Med 4:S28-33. 2003
  7. ncbi Clinical significance and preventive strategies for contrast-induced nephropathy
    Kevin A Sterling
    Division of Nephrology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Curr Opin Nephrol Hypertens 17:616-23. 2008

Detail Information

Publications7

  1. ncbi Contrast-induced nephropathy: how it develops, how to prevent it
    Michael R Rudnick
    University of Pennsylvania School of Medicine, Philadelphia, USA
    Cleve Clin J Med 73:75-80, 83-7. 2006
    ..Many preventive measures have failed to show benefits in well-designed, prospective, randomized, double-blinded trials. This review will focus only on the prophylactic strategies that have possible or proven value...
  2. ncbi Contrast-induced nephropathy: is the picture any clearer?
    Michael R Rudnick
    Section of Nephrology and Hypertension, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Clin J Am Soc Nephrol 3:261-2. 2008
  3. ncbi Contrast-induced nephropathy: what are the true clinical consequences?
    Michael Rudnick
    Renal Electrolyte and Hypertension Division, Penn Presbyterian Medical Center, Philadelphia, Pennsylvania 19104, USA
    Clin J Am Soc Nephrol 3:263-72. 2008
    ..The more clinically relevant questions, and the objectives of this review, are whether CIN is causally related to mortality, and to what extent could mortality in patients undergoing contrast procedures be reduced by preventing CIN...
  4. ncbi Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial
    Michael R Rudnick
    Division of Nephrology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Am Heart J 156:776-82. 2008
    ..This study compared the nephrotoxicity of iodixanol and the LOCM ioversol in CKD patients undergoing coronary angiography...
  5. ncbi Hemodialysis-related venous stenosis: treatment with ultrahigh-pressure angioplasty balloons
    Scott O Trerotola
    Department of Radiology, University of Pennsylvania Medical Center, 1 Silverstein, 3400 Spruce St, Philadelphia, PA 19104, USA
    Radiology 231:259-62. 2004
    ..This approach could potentially offer cost savings compared with the costs of other previously described treatment methods for resistant lesions, such as atherectomy devices and cutting balloons...
  6. ncbi Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality
    Michael R Rudnick
    Division of Nephrology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Rev Cardiovasc Med 4:S28-33. 2003
    ..Whether iso-osmolar contrast media are the least nephrotoxic iodinated contrast media needs to be determined with large prospective randomized clinical trials...
  7. ncbi Clinical significance and preventive strategies for contrast-induced nephropathy
    Kevin A Sterling
    Division of Nephrology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Curr Opin Nephrol Hypertens 17:616-23. 2008
    ..Published studies on pathogenesis, clinical significance, diagnosis, and preventive measures have dramatically increased significantly in the past several years. This review will focus on new developments in contrast-induced nephropathy...